Search Results

81 - 90 of 103
The Genomics Landscape
In the July 2021 issue of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., reflects on the legacy the LINCS program leaves as it has completed its goal of creating a large-scale, systematically generated molecular and cellular dataset.
… genetic testing, obstetrics/gynecology education, pharmacogenomics, rare diseases, and inclusive genomics. …
File
… Committee. Joint collaborations will be held with the Pharmacogenomics Research Netwo rk, the International Society …
Research at NHGRI
A list of publications led by or in collaboration with the Center for Research on Genomics and Global Health.
… [ PubMed ] Baker JL , Shriner D , Bentley AR , Rotimi CN . Pharmacogenomics and Infectious Diseases in Africa: An … the evolutionary history of infectious diseases in Africa. Pharmacogenomics J . 17(2):112-120. 2017. [ PubMed ] Kruszka … E, Finan C, Davey G,  Rotimi CN , Newport MJ. Clinical and pharmacogenomics implications of genetic variation in a …
eMERGE
Important information about RFAs, upcoming dates, frequently asked questions and helpful links.
File
… a unique genomic medicine intervention involv ing pharmacogenomics, molecular ly targeted therapy, or complex …
The Genomics Landscape
NHGRI medical genetics training programs provide an array of education opportunities
The Genomics Landscape
In the June 2021 issue of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D. details the upcoming appointment of acting NHGRI Deputy Director, Vence Bonham Jr., J.D. and what it means for the institute.
… five days will include direct-to-consumer genetic testing, pharmacogenomics, cancer genomics, and rare diseases. The …
Research Funding
The Division of Genomic Medicine promotes the NHGRI's efforts to advance the application of genomics to medical science and clinical care.
… California   Genomic Medicine X: Research Directions in Pharmacogenomics Implementation May 2-3, 2017, Silver Spring, …
File
… disease testing and genetic and genomic testing for pharmacogenomics and acquired conditions (such as the somatic …